Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",3.928286805344672e-08,4.059987576537403,69.2328461516496,"['GPR27', 'NPFFR1', 'CHRM5', 'HTR2B', 'ADRA1D', 'MCHR1', 'MC4R', 'HRH1', 'HTR7', 'GPER1', 'NTSR1', 'P2RY12', 'GPR39', 'HTR1F', 'P2RY14', 'NPY1R', 'OPRK1', 'NMBR', 'GPR3', 'SSTR1', 'ADRA2C', 'ADRA2A', 'HCRTR2', 'ADORA2A', 'LPAR6', 'ACKR4', 'OR6A2', 'RGL4']",1.877721092954753e-05,0,0,28
2,Vitamin D Receptor Pathway WP2877,7.831766933307695e-05,2.882880353023769,27.256876458345157,"['COLEC11', 'ABCB1', 'TGFB1', 'CDKN1B', 'CDKN2C', 'IGFBP5', 'IGFBP3', 'G0S2', 'ATP2C2', 'CYP3A5', 'ADAMTS5', 'CEACAM1', 'DUSP10', 'CCND1', 'BGLAP', 'CLMN', 'ALOX5', 'DND1', 'PNOC', 'TIMP2', 'SOSTDC1', 'LGALS9']",0.01871792297060539,0,0,22
3,Proximal tubule transport WP4917,0.00028313528390161473,4.07440414507772,33.28619400081204,"['SLC47A2', 'ATP6V1G1', 'ATP6V0B', 'SLC22A6', 'ABCC2', 'SLC7A7', 'ABCB1', 'SLC3A1', 'ATP6V0A4', 'SLC4A2', 'ATP6V0C', 'ATP6V1F']",0.04511288856832395,0,0,12
4,Peptide GPCRs WP24,0.00037752345177090665,4.71216041397154,37.140672874088885,"['MC4R', 'GNRHR', 'NPY1R', 'TAC4', 'OPRK1', 'SSTR1', 'NMBR', 'NTSR1', 'TSHR', 'HCRTR2']",0.04511405248662335,0,0,10
5,Galanin receptor pathway WP4970,0.0007354229408977516,8.46774193548387,61.09530672723836,"['CDKN1C', 'YAP1', 'CDKN1B', 'PRKCD', 'VAMP2', 'VEGFA']",0.07030643314982506,0,0,6
6,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.0011870555251596668,inf,inf,"['TGFB1', 'IL5', 'VIP']",0.0943276497688776,0,0,3
7,Allograft Rejection WP2328,0.0014629109445995123,3.455447680690399,22.55483704888249,"['C1QB', 'C1QA', 'CASP7', 'CASP8', 'ABCB1', 'C6', 'TGFB1', 'IL5', 'HLA-A', 'HLA-E', 'VEGFA']",0.0943276497688776,0,0,11
8,Drug Induction of Bile Acid Pathway WP2289,0.0015787054354623865,16.91881443298969,109.14581163162475,"['ABCB1', 'ABCC2', 'SLC10A1', 'SLC51A']",0.0943276497688776,0,0,4
9,Monoamine GPCRs WP58,0.002417835702760089,4.236111111111111,25.52207160257969,"['HRH1', 'HTR7', 'HTR1F', 'CHRM5', 'HTR2B', 'ADRA1D', 'ADRA2C', 'ADRA2A']",0.1284139406577025,0,0,8
10,Nuclear Receptors Meta-Pathway WP2882,0.0038331109318555786,1.7235770503889667,9.59011809834217,"['CDKN1C', 'ABCB1', 'CDKN1B', 'HSP90AB1', 'SRXN1', 'ABCB4', 'GSTP1', 'PDGFB', 'SLC5A3', 'CYP3A5', 'SLC5A4', 'CYP3A7', 'DNAJB1', 'RGS2', 'CCND1', 'CPT2', 'SLC39A8', 'CBR3', 'GSTM2', 'ABCG5', 'HSP90AA1', 'GPX2', 'TGFB1', 'ABCC2', 'SLC10A1', 'TSC22D3', 'SLC2A12', 'AIP', 'SLC7A5', 'B3GNT5', 'MAFF', 'SPINK13', 'SPRY1', 'MFGE8', 'GSTM5']",0.18322270254269665,0,0,35
11,Complement and Coagulation Cascades WP558,0.005473171930331471,3.566435468516252,18.573628409692336,"['C1QB', 'C1QA', 'CPB2', 'C6', 'SERPIND1', 'F10', 'MASP2', 'F5']",0.23783419842713122,0,0,8
12,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.006183000656070723,4.617008797653959,23.481883199906903,"['CYP26A1', 'ABCD2', 'ABCG5', 'ABCB1', 'ABCC2', 'ABCB4']",0.24628952613348382,0,0,6
13,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.006963899810834776,3.3878552971576226,16.82753026027326,"['NFKBIA', 'CASP7', 'HSP90AA1', 'CASP8', 'ACAP1', 'IL18', 'NLRC4', 'AAMP']",0.25605723919838635,0,0,8
14,Cori Cycle WP1946,0.008233491631697513,5.288120567375887,25.380573145085364,"['LDHA', 'TPI1', 'PGAM1', 'ALDOA', 'GAPDH']",0.28111492856795794,0,0,5
15,Cytokines and Inflammatory Response WP530,0.01020639414510583,6.765979381443299,31.02026225066105,"['CD4', 'TGFB1', 'IL5', 'IL7']",0.3252437600907058,0,0,4
16,Hypertrophy Model WP516,0.011706246610978582,4.700193423597679,20.90473387911729,"['NR4A3', 'MSTN', 'IL1R1', 'IL18', 'VEGFA']",0.34972411750298515,0,0,5
17,Complement Activation WP545,0.015600620987012884,5.637886597938144,23.456114618728915,"['C1QB', 'C1QA', 'C6', 'MASP2']",0.43865275481130345,0,0,4
18,Prader-Willi and Angelman Syndrome WP3998,0.01738729836856362,2.420255036037701,9.806910479840178,"['GABRR2', 'MAGEL2', 'CDKN2C', 'CCND1', 'DLX5', 'SNURF', 'NDN', 'GNRH1', 'ATP10A', 'TYR']",0.4434774536681174,0,0,10
19,Selenium Micronutrient Network WP15,0.018548354639973116,2.2731075854447864,9.06373052301579,"['SERPINA3', 'PRDX2', 'GPX2', 'SELENOM', 'GPX4', 'RFK', 'ALOX5', 'DIO1', 'PNPO', 'KMO', 'SEPHS2']",0.4434774536681174,0,0,11
20,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.0185555419944819,8.453316162266582,33.70325974163731,"['HEY1', 'VEGFC', 'VEGFA']",0.4434774536681174,0,0,3
21,NRF2 pathway WP2884,0.021079221105018094,1.848528015194682,7.134333807592878,"['GSTM2', 'HSP90AA1', 'GPX2', 'TGFB1', 'HSP90AB1', 'ABCC2', 'SRXN1', 'GSTP1', 'SLC2A12', 'PDGFB', 'SLC5A3', 'SLC5A4', 'DNAJB1', 'MAFF', 'SLC39A8', 'GSTM5', 'CBR3']",0.4640172078524447,0,0,17
22,Pregnane X receptor pathway WP2876,0.021356440528773606,3.845026669011195,14.789517964780464,"['HSP90AA1', 'ABCB1', 'ABCC2', 'CYP3A5', 'CYP3A7']",0.4640172078524447,0,0,5
23,Computational Model of Aerobic Glycolysis WP4629,0.022491802291785136,4.832106038291605,18.33593073147586,"['LDHA', 'TPI1', 'ALDOA', 'GAPDH']",0.4674383258901433,0,0,4
24,Differentiation Pathway WP2848,0.028575034211985262,2.692734315394096,9.573267933660619,"['TGFB1', 'EGF', 'FST', 'PDGFB', 'FGF1', 'DKK1', 'VEGFA']",0.4983739626546254,0,0,7
25,Glycolysis and Gluconeogenesis WP534,0.028575034211985262,2.692734315394096,9.573267933660619,"['LDHA', 'TPI1', 'PGAM1', 'ALDOC', 'ENO2', 'ALDOA', 'GAPDH']",0.4983739626546254,0,0,7
26,"GPCRs, Other WP117",0.029256504020938302,2.3091026620438386,8.154950198850466,"['ADGRE2', 'HTR7', 'ADGRV1', 'ADORA2A', 'HTR1F', 'GNRHR', 'ADRA1D', 'MCHR2', 'NTSR1']",0.4983739626546254,0,0,9
27,NAD Biosynthesis II (from tryptophan) WP2485,0.029941307690681786,6.339504185447521,22.242253286130854,"['NMNAT1', 'HAAO', 'KMO']",0.4983739626546254,0,0,3
28,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.030965154852756593,4.227770618556701,14.691049444485541,"['BMP2', 'SST', 'DKK1', 'DCN']",0.4983739626546254,0,0,4
29,Dopaminergic Neurogenesis WP2855,0.030965154852756593,4.227770618556701,14.691049444485541,"['CDKN1C', 'TGFB1', 'ASCL1', 'SLC18A2']",0.4983739626546254,0,0,4
30,Gastric acid production WP2596,0.03127870058501833,16.8983268983269,58.54962561145704,"['VIP', 'MUC6']",0.4983739626546254,0,0,2
31,Metapathway biotransformation Phase I and II WP702,0.03314671960992889,1.7365054760954148,5.915946866073296,"['CHST9', 'GSTM2', 'GPX2', 'NNMT', 'GPX4', 'GSTP1', 'KCNAB1', 'GLYAT', 'CYP2C18', 'CYP3A5', 'FMO5', 'CYP3A7', 'CYP26A1', 'GAL3ST2', 'SULT4A1', 'CHST2', 'GSTM5']",0.5074777303712056,0,0,17
32,Lung fibrosis WP3624,0.03397340454367904,2.5754624301793583,8.710670516235014,"['TGFB1', 'IL5', 'EGF', 'SFTPC', 'FAM13A', 'PDGFB', 'FGF1']",0.5074777303712056,0,0,7
33,Major receptors targeted by epinephrine and norepinephrine WP4589,0.04106813120690784,3.7577319587628866,11.996645160115142,"['ADCY10', 'ADRA1D', 'ADRA2C', 'ADRA2A']",0.5559277110359894,0,0,4
34,Bile acids synthesis and enterohepatic circulation  WP4389,0.04419508999867698,5.071216999356085,15.817843814400817,"['ABCG5', 'SLC10A1', 'FGFR4']",0.5559277110359894,0,0,3
35,HIF1A and PPARG regulation of glycolysis WP2456,0.04419508999867698,5.071216999356085,15.817843814400817,"['LDHA', 'TPI1', 'GAPDH']",0.5559277110359894,0,0,3
36,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.04419508999867698,5.071216999356085,15.817843814400817,"['CCND1', 'EGF', 'FN1']",0.5559277110359894,0,0,3
37,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.04419508999867698,5.071216999356085,15.817843814400817,"['MMP25', 'CD4', 'CD247']",0.5559277110359894,0,0,3
38,Selective expression of chemokine receptors during T-cell polarization WP4494,0.04419508999867698,5.071216999356085,15.817843814400817,"['CD4', 'TGFB1', 'IL5']",0.5559277110359894,0,0,3
39,Oxidative Damage WP3941,0.054066556377950915,2.2777722600188706,6.645490462792169,"['C1QB', 'CDKN1C', 'C1QA', 'PCNA', 'CDKN1B', 'CYCS', 'NFKBIE']",0.662661896119501,0,0,7
40,Codeine and Morphine Metabolism WP1604,0.05818583761262986,8.448519948519948,24.028547898907874,"['ABCB1', 'ABCC2']",0.6783617165570017,0,0,2
41,Nucleotide GPCRs WP80,0.05818583761262986,8.448519948519948,24.028547898907874,"['ADORA2A', 'LPAR6']",0.6783617165570017,0,0,2
42,Blood Clotting Cascade WP272,0.06118946050659351,4.225692208628461,11.805655723401793,"['F8A1', 'F10', 'F5']",0.6801991191198069,0,0,3
43,Osteoclast Signaling WP12,0.06118946050659351,4.225692208628461,11.805655723401793,"['AIMP2', 'ATP6V1G1', 'PDGFB']",0.6801991191198069,0,0,3
44,Unfolded protein response WP4925,0.06396582234098833,2.6424484203739524,7.265164504012428,"['PPP1R15A', 'XBP1', 'CASP8', 'HSPA5', 'TXNIP']",0.6949014336134641,0,0,5
45,TYROBP causal network in microglia WP3945,0.06906395296086355,2.306568914956012,6.164818288843811,"['CD4', 'SLC7A7', 'IGSF6', 'LOXL3', 'IL18', 'SAMSN1']",0.733612655895395,0,0,6
46,Fas ligand pathway and stress induction of heat shock proteins WP314,0.07086094083610239,2.114751452550032,5.597823019213003,"['CASP7', 'CASP8', 'MAPKAPK3', 'HSPB1', 'CYCS', 'ACTB', 'ACTG1']",0.7363376026012379,0,0,7
47,Ferroptosis WP4313,0.08029738780071133,2.0416731595467597,5.149136844493092,"['PRNP', 'MAP1LC3B', 'GPX4', 'PCBP1', 'ACSL5', 'SLC39A8', 'CP']",0.81664151848383,0,0,7
48,Sleep regulation WP3591,0.08885129312750198,2.3484848484848486,5.685191385113888,"['CHRNB2', 'ADORA2A', 'IL18', 'CRH', 'HCRTR2']",0.8171089644959547,0,0,5
49,ACE Inhibitor Pathway WP554,0.09026502950037896,5.631917631917632,13.544790986711083,"['TGFB1', 'ATP6AP2']",0.8171089644959547,0,0,2
50,EV release from cardiac cells and their functional effects WP3297,0.09026502950037896,5.631917631917632,13.544790986711083,"['RGS16', 'MYB']",0.8171089644959547,0,0,2
51,Metabolism of alpha-linolenic acid WP4586,0.09026502950037896,5.631917631917632,13.544790986711083,"['ALOX5', 'ALOX12']",0.8171089644959547,0,0,2
52,Constitutive Androstane Receptor Pathway WP2875,0.09756455721597515,2.6007137192704204,6.052487583210652,"['HSP90AA1', 'ABCB1', 'ABCC2', 'CYP3A5']",0.8171089644959547,0,0,4
53,Nanomaterial induced apoptosis WP2507,0.09756455721597515,2.6007137192704204,6.052487583210652,"['CASP7', 'ENDOG', 'CASP8', 'CYCS']",0.8171089644959547,0,0,4
54,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.09836445245100375,1.469023086817573,3.406775884068427,"['CHRNB2', 'DLX2', 'TSPYL1', 'SSTR1', 'ASCL1', 'VEGFA', 'PRKAR1A', 'SST', 'KCNQ1', 'PAH', 'MYB', 'CHRFAM7A', 'TAC1', 'ALDOA', 'GAPDH', 'YWHAG', 'VAMP2']",0.8171089644959547,0,0,17
55,Development and heterogeneity of the ILC family WP3893,0.1025659788070236,3.168786220218931,7.216115225250536,"['IL5', 'IL7', 'IL18']",0.8171089644959547,0,0,3
56,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.1025659788070236,3.168786220218931,7.216115225250536,"['CCND1', 'ROS1', 'PHEX']",0.8171089644959547,0,0,3
57,Glutathione metabolism WP100,0.1025659788070236,3.168786220218931,7.216115225250536,"['GPX2', 'GSTM2', 'GPX4']",0.8171089644959547,0,0,3
58,Glycolysis in senescence WP5049,0.1025659788070236,3.168786220218931,7.216115225250536,"['LDHA', 'ALDOC', 'GAPDH']",0.8171089644959547,0,0,3
59,Inflammatory Response Pathway WP453,0.1025659788070236,3.168786220218931,7.216115225250536,"['IL5', 'LAMB2', 'FN1']",0.8171089644959547,0,0,3
60,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.1025659788070236,3.168786220218931,7.216115225250536,"['PTTG1', 'BUB3', 'MAD2L1']",0.8171089644959547,0,0,3
61,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.1059437775572512,inf,inf,['FMO5'],0.8301823880715751,0,0,1
62,Myometrial relaxation and contraction pathways WP289,0.10994275967956446,1.4245469902653038,3.14510831381164,"['PRKCH', 'IGFBP5', 'IGFBP3', 'RGS16', 'PRKCD', 'ACTB', 'ACTG1', 'RGS4', 'RGS5', 'RGS2', 'PRKAR1A', 'GNG4', 'MAFF', 'CRH', 'CALM3', 'ATF5', 'YWHAG', 'CORIN']",0.8476232117230937,0,0,18
63,Purinergic signaling WP4900,0.11541952183017078,2.414764359351988,5.2139151897788265,"['P2RY12', 'ADORA2A', 'LPAR6', 'P2RY14']",0.8757227211876449,0,0,4
64,Aryl Hydrocarbon Receptor Pathway WP2873,0.11801390333565726,2.1133139909735656,4.516052327592682,"['SLC7A5', 'HSP90AA1', 'CDKN1B', 'TGFB1', 'AIP']",0.8814163405381902,0,0,5
65,Irinotecan pathway WP229,0.12611980239431447,4.223616473616474,8.745095098740537,"['ABCC2', 'CYP3A5']",0.883685330629948,0,0,2
66,Osteoblast Signaling WP322,0.12611980239431447,4.223616473616474,8.745095098740537,"['BGLAP', 'PDGFB']",0.883685330629948,0,0,2
67,ID signaling pathway WP53,0.12643293425080698,2.816484224082421,5.82461125995831,"['PAX8', 'ID3', 'ELK3']",0.883685330629948,0,0,3
68,IL1 and megakaryocytes in obesity WP2865,0.12643293425080698,2.816484224082421,5.82461125995831,"['IL1R1', 'IL18', 'TIMP2']",0.883685330629948,0,0,3
69,Spinal Cord Injury WP2431,0.12756127157628958,1.5154280411414431,3.1205064842181964,"['C1QB', 'TGFB1', 'CDKN1B', 'CCND1', 'PRB1', 'IL1R1', 'MIF', 'PDYN', 'ROS1', 'NTN1', 'TNFSF13B', 'RHOB']",0.883685330629948,0,0,12
70,Glucocorticoid Receptor Pathway WP2880,0.13022742055695277,1.691343669250646,3.447758349408385,"['CDKN1C', 'RGS2', 'HSP90AA1', 'TSC22D3', 'B3GNT5', 'SPINK13', 'SPRY1', 'MFGE8']",0.8892672432317632,0,0,8
71,Genes controlling nephrogenesis WP4823,0.13408344834093902,2.012526480611587,4.043755216947706,"['LAMB2', 'PDGFB', 'ETV4', 'GLI3', 'VEGFA']",0.8934522933731268,0,0,5
72,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.1345785881231488,2.2536082474226804,4.519852368707406,"['MAPK11', 'ABCC2', 'SRXN1', 'GSTP1']",0.8934522933731268,0,0,4
73,Acute viral myocarditis WP4298,0.14460186221880134,1.5856900452488687,3.066361568670534,"['CASP7', 'CD4', 'CASP8', 'ENDOG', 'TGFB1', 'CCND1', 'CYCS', 'ACTB', 'SGCG']",0.9285328653796673,0,0,9
74,Bladder cancer WP2828,0.14477109730305296,1.8114746543778801,3.500858495168205,"['RPS6KA5', 'CCND1', 'EGF', 'DAPK2', 'TYMP', 'VEGFA']",0.9285328653796673,0,0,6
75,Senescence and Autophagy in Cancer WP615,0.14569030314534528,1.4712773147105205,2.8340804744140247,"['BMP2', 'MAP1LC3B', 'TGFB1', 'CDKN1B', 'PCNA', 'IGFBP5', 'IGFBP3', 'IRF1', 'FKBP8', 'FN1', 'CXCL14', 'GABARAP']",0.9285328653796673,0,0,12
76,Matrix Metalloproteinases WP129,0.15204238627485334,2.534642627173213,4.774242561736905,"['MMP25', 'TIMP2', 'MMP21']",0.9438475407711675,0,0,3
77,Tryptophan catabolism leading to NAD+ production WP4210,0.15204238627485334,2.534642627173213,4.774242561736905,"['NMNAT1', 'HAAO', 'KMO']",0.9438475407711675,0,0,3
78,Ketogenesis and Ketolysis WP4742,0.16459121990865389,3.3786357786357786,6.096039878008054,"['CPT2', 'BDH1']",0.9732192300601109,0,0,2
79,Role of Osx and miRNAs in tooth development WP3971,0.16459121990865389,3.3786357786357786,6.096039878008054,"['NOTCH4', 'DKK1']",0.9732192300601109,0,0,2
80,Sulfation Biotransformation Reaction WP692,0.16459121990865389,3.3786357786357786,6.096039878008054,"['SULT4A1', 'PAPSS2']",0.9732192300601109,0,0,2
81,Complement system WP2806,0.16491790300181797,1.6438024531956101,2.962637467670779,"['PRNP', 'C6', 'F10', 'WAS', 'C4BPA', 'MASP2', 'DCN']",0.9732192300601109,0,0,7
82,IL-18 signaling pathway WP4754,0.17298585142807602,1.2620209850315425,2.2142732042017945,"['TICAM2', 'IMP3', 'RGS16', 'PRKCD', 'MEPCE', 'FN1', 'IL18', 'HSPB1', 'BPGM', 'RND2', 'VEGFA', 'NFKBIA', 'CCNA2', 'ADAMTS5', 'ARL4D', 'BMP2', 'CASP8', 'FAM186B', 'IRF1', 'CYCS', 'NFKBIE', 'SNTB1', 'ARF6', 'MYH7']",0.9840480607097993,0,0,24
83,Heart Development WP1591,0.17632431239810836,1.9881746513038205,3.450338522664342,"['BMP2', 'HEY1', 'VEGFC', 'VEGFA']",0.9840480607097993,0,0,4
84,Type II interferon signaling (IFNG) WP619,0.17632431239810836,1.9881746513038205,3.450338522664342,"['CIITA', 'SPI1', 'IRF1', 'PRKCD']",0.9840480607097993,0,0,4
85,Calcium Regulation in the Cardiac Cell WP536,0.17787901471500409,1.3196583030801605,2.278590189614277,"['KCNJ5', 'PRKCH', 'RGS16', 'CHRM5', 'PRKCD', 'ADRA1D', 'RGS4', 'GJD2', 'RGS5', 'RGS2', 'PLN', 'PRKAR1A', 'GNG4', 'GJA9', 'CALM3', 'CASQ1', 'YWHAG']",0.9840480607097993,0,0,17
86,ERK Pathway in Huntington's Disease WP3853,0.17910498176098857,2.3040449569747703,3.962457704848903,"['CASP7', 'RPS6KA5', 'EGF']",0.9840480607097993,0,0,3
87,GDNF/RET signaling axis WP4830,0.17910498176098857,2.3040449569747703,3.962457704848903,"['SALL1', 'SPRY1', 'GLI3']",0.9840480607097993,0,0,3
88,Nephrotic syndrome WP4758,0.19258215973633808,1.63579604578564,2.6945362668312844,"['MYO1E', 'ANLN', 'LAMB2', 'PMM2', 'GPC5', 'EMP2']",0.999985189739908,0,0,6
89,COVID-19 adverse outcome pathway WP4891,0.20067001813486052,8.443729903536978,13.561419045185609,['IL7'],0.999985189739908,0,0,1
90,Thyroxine (Thyroid Hormone) Production WP1981,0.20067001813486052,8.443729903536978,13.561419045185609,['TSHR'],0.999985189739908,0,0,1
91,Canonical NF-KB pathway WP4562,0.20472327490179693,2.815315315315315,4.4653606145222495,"['NFKBIA', 'NFKBIE']",0.999985189739908,0,0,2
92,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.2061990338832474,1.4355478040272713,2.266605653709401,"['TUBB8', 'HSPA8', 'TUBB6', 'CASP8', 'TUBB2A', 'HSPA1L', 'HSPA5', 'UBE2L6', 'HSPA1B']",0.999985189739908,0,0,9
93,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.20733630332867786,2.111880231809401,3.322860128539536,"['HPGD', 'ALOX5', 'ALOX12']",0.999985189739908,0,0,3
94,Vitamin A and carotenoid metabolism WP716,0.2266813646922976,1.624882209988593,2.4116663068421835,"['CYP26A1', 'ABCG5', 'RBP2', 'ALDH1A2', 'BCO1']",0.999985189739908,0,0,5
95,Kynurenine Pathway and links to Cellular Senescence WP5044,0.23646295563724817,1.9492793105156274,2.8107900441599316,"['HAAO', 'KMO', 'ACMSD']",0.999985189739908,0,0,3
96,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.23646295563724817,1.9492793105156274,2.8107900441599316,"['BMP2', 'TGFB1', 'FN1']",0.999985189739908,0,0,3
97,Phosphodiesterases in neuronal function WP4222,0.24214793022959363,1.4427876363979908,2.046170742945211,"['ADCY10', 'PDE10A', 'ADORA2A', 'PDE6C', 'PDE5A', 'PDE6B', 'CHRFAM7A']",0.999985189739908,0,0,7
98,Cytosine methylation WP3585,0.2457329412740677,2.4129435558006986,3.3865902587638597,"['TDG', 'TET3']",0.999985189739908,0,0,2
99,EDA signaling in hair follicle development WP3930,0.2457329412740677,2.4129435558006986,3.3865902587638597,"['SOSTDC1', 'DKK1']",0.999985189739908,0,0,2
100,Farnesoid X receptor pathway WP2879,0.2457329412740677,2.4129435558006986,3.3865902587638597,"['SLC10A1', 'ABCB4']",0.999985189739908,0,0,2
101,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.2457329412740677,2.4129435558006986,3.3865902587638597,"['ANXA2', 'LDLRAP1']",0.999985189739908,0,0,2
102,Development of ureteric collection system WP5053,0.247113938898031,1.564581990113905,2.187138172266057,"['SALL1', 'CCND1', 'SPRY1', 'ETV4', 'GLI3']",0.999985189739908,0,0,5
103,Apoptosis Modulation by HSP70 WP384,0.2662268983603681,1.8099070922638212,2.3952425070382866,"['CASP7', 'CASP8', 'CYCS']",0.999985189739908,0,0,3
104,"GPCRs, Class B Secretin-like WP334",0.2662268983603681,1.8099070922638212,2.3952425070382866,"['ADGRE2', 'CALCR', 'ADGRG2']",0.999985189739908,0,0,3
105,Imatinib and Chronic Myeloid Leukemia WP3640,0.2662268983603681,1.8099070922638212,2.3952425070382866,"['SPRED2', 'ABCB1', 'CDKN1B']",0.999985189739908,0,0,3
106,Hematopoietic Stem Cell Differentiation WP2849,0.26982568695327824,1.6089837997054492,2.1077352019072646,"['CIITA', 'SPI1', 'IL5', 'MYB']",0.999985189739908,0,0,4
107,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.26982568695327824,1.6089837997054492,2.1077352019072646,"['RAB3B', 'RAB3A', 'HSPB1', 'RABAC1']",0.999985189739908,0,0,4
108,16p11.2 proximal deletion syndrome WP4949,0.2764836826940984,1.3112921561197424,1.6858017507145333,"['CASP8', 'PCNA', 'IGFBP3', 'KCTD13', 'GDPD3', 'ALDOA', 'CDIPT', 'YPEL3', 'CCT6B']",0.999985189739908,0,0,9
109,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.28462131088411335,1.3254293965648274,1.6655289015876316,"['CDKN1C', 'MYO1E', 'CDKN1B', 'PCNA', 'TGFB1', 'LAMB2', 'FAT1', 'DKK1']",0.999985189739908,0,0,8
110,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.28536568356211717,4.221543408360128,5.29374713358568,['VEGFA'],0.999985189739908,0,0,1
111,miR-509-3p alteration of YAP1/ECM axis WP3967,0.28698428755813987,2.1111647361647363,2.635425655668323,"['YAP1', 'FN1']",0.999985189739908,0,0,2
112,Tryptophan metabolism WP465,0.294506091966161,1.5357310215557638,1.8773629725149088,"['HAAO', 'ALDH1A2', 'CYP2C18', 'ACMSD']",0.999985189739908,0,0,4
113,Osteoblast differentiation WP4787,0.3141170533208113,1.2230028955884857,1.4162246109460588,"['MAPK11', 'BMP2', 'PRKCH', 'HEY1', 'NOTCH4', 'PRKCD', 'FGF1', 'FGFR4', 'WNT16', 'GLI3', 'DLL3']",0.999985189739908,0,0,11
114,Cardiac Progenitor Differentiation WP2406,0.31945225640682595,1.4688480502017032,1.6761722047911456,"['TGFB1', 'TNNT2', 'THY1', 'DKK1']",0.999985189739908,0,0,4
115,Oxidation by Cytochrome P450 WP43,0.31945225640682595,1.4688480502017032,1.6761722047911456,"['CYP26A1', 'CYP3A5', 'CYP2C18', 'CYP3A7']",0.999985189739908,0,0,4
116,Cytosolic DNA-sensing pathway WP4655,0.3211869035760158,1.3337521222410866,1.5147850602141135,"['NFKBIA', 'CASP8', 'RNF125', 'POLR1C', 'IL18', 'POLR2K']",0.999985189739908,0,0,6
117,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.32672770172426585,1.583427237604636,1.7712663153867918,"['H3F3B', 'H2AFZ', 'PCGF1']",0.999985189739908,0,0,3
118,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.32672770172426585,1.583427237604636,1.7712663153867918,"['MAPK11', 'CASP7', 'CASP8']",0.999985189739908,0,0,3
119,Kallmann's Syndrome WP5074,0.32672770172426585,1.583427237604636,1.7712663153867918,"['TMEM98', 'GNRH1', 'ASCL1']",0.999985189739908,0,0,3
120,Cancer immunotherapy by PD-1 blockade WP4585,0.32796612902156863,1.8764478764478765,2.0919484223114275,"['HLA-A', 'PDCD1LG2']",0.999985189739908,0,0,2
121,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.32796612902156863,1.8764478764478765,2.0919484223114275,"['TGFB1', 'CCND1']",0.999985189739908,0,0,2
122,Hepatitis C and Hepatocellular Carcinoma WP3646,0.3325031546694799,1.3622844782762422,1.5000195190164052,"['CASP7', 'TGFB1', 'CCND1', 'BRCA1', 'VEGFA']",0.999985189739908,0,0,5
123,Canonical and non-canonical Notch signaling WP3845,0.3570462268976678,1.4901708268626188,1.534712060411305,"['HEY1', 'NOTCH4', 'DLL3']",0.999985189739908,0,0,3
124,Exercise-induced Circadian Regulation WP410,0.3603075644449379,1.2668709677419354,1.2932184210022388,"['PER2', 'HSPA8', 'CLDN5', 'RBPMS', 'GSTP1', 'G0S2']",0.999985189739908,0,0,6
125,Cells and molecules involved in local acute inflammatory response  WP4493,0.36109228602923116,2.8141479099678457,2.8665521656701256,['C6'],0.999985189739908,0,0,1
126,Platelet-mediated interactions with vascular and circulating cells WP4462,0.36109228602923116,2.8141479099678457,2.8665521656701256,['TGFB1'],0.999985189739908,0,0,1
127,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.36109228602923116,2.8141479099678457,2.8665521656701256,['VEGFA'],0.999985189739908,0,0,1
128,Synthesis and Degradation of Ketone Bodies WP311,0.36109228602923116,2.8141479099678457,2.8665521656701256,['BDH1'],0.999985189739908,0,0,1
129,Vitamin B6-dependent and responsive disorders WP4228,0.36109228602923116,2.8141479099678457,2.8665521656701256,['PNPO'],0.999985189739908,0,0,1
130,Focal Adhesion WP306,0.3652310073387577,1.1148747560182173,1.1229299811868787,"['SHC4', 'SHC3', 'LAMB3', 'EGF', 'LAMB2', 'TXK', 'PDGFB', 'FN1', 'TESK2', 'VEGFC', 'ACTB', 'VEGFA', 'ACTG1', 'MYLPF', 'MYL5', 'HCK', 'RELN', 'CCND1', 'PDGFD']",0.999985189739908,0,0,19
131,FOXA2 pathway WP5066,0.3682727592568265,1.6886743886743887,1.686869907915641,"['GSTM2', 'ABCC2']",0.999985189739908,0,0,2
132,Genes targeted by miRNAs in adipocytes WP1992,0.3682727592568265,1.6886743886743887,1.686869907915641,"['KCNE1', 'KCNQ1']",0.999985189739908,0,0,2
133,IL-6 signaling pathway WP364,0.3762833115991075,1.2795264052517437,1.2506256540829512,"['HCK', 'IRF1', 'PRKCD', 'GAB1', 'VIP']",0.999985189739908,0,0,5
134,Pathways in clear cell renal cell carcinoma WP4018,0.38357623753859726,1.1694495549699169,1.1205863083579037,"['LDHA', 'TPI1', 'TGFB1', 'PDGFB', 'ALDOC', 'ENO2', 'ALDOA', 'GAPDH', 'VEGFA']",0.999985189739908,0,0,9
135,Angiogenesis WP1539,0.38716653801850437,1.4072762395363811,1.3353649130354732,"['PDGFB', 'TIMP2', 'VEGFA']",0.999985189739908,0,0,3
136,IL-7 signaling pathway WP205,0.38716653801850437,1.4072762395363811,1.3353649130354732,"['CDKN1B', 'CCND1', 'IL7']",0.999985189739908,0,0,3
137,Microglia Pathogen Phagocytosis Pathway WP3937,0.38716653801850437,1.4072762395363811,1.3353649130354732,"['C1QB', 'C1QA', 'HCK']",0.999985189739908,0,0,3
138,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.38716653801850437,1.4072762395363811,1.3353649130354732,"['BMP2', 'PDGFB', 'ASCL1']",0.999985189739908,0,0,3
139,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.3996791598910694,1.2063594470046084,1.1063439901123862,"['CASP7', 'CDKN1B', 'HSPA5', 'HSPB1', 'YBX3', 'ETS1']",0.999985189739908,0,0,6
140,Pathogenic Escherichia coli infection WP2272,0.3996791598910694,1.2063594470046084,1.1063439901123862,"['TUBB8', 'TUBB6', 'TUBB2A', 'WAS', 'ACTB', 'ACTG1']",0.999985189739908,0,0,6
141,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.4075873606411115,1.535041535041535,1.3776997582605741,"['CCND1', 'SOX4']",0.999985189739908,0,0,2
142,miRNAs involved in DNA damage response WP1545,0.4075873606411115,1.535041535041535,1.3776997582605741,"['CDKN1B', 'CCND1']",0.999985189739908,0,0,2
143,NOTCH1 regulation of endothelial cell calcification WP3413,0.4075873606411115,1.535041535041535,1.3776997582605741,"['VEGFA', 'DLL3']",0.999985189739908,0,0,2
144,Alpha 6 Beta 4 signaling pathway WP244,0.4196324010384618,1.2508591065292096,1.086216260863899,"['LAMB3', 'LAMB2', 'PRKCD', 'GAB1']",0.999985189739908,0,0,4
145,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.4196324010384618,1.2508591065292096,1.086216260863899,"['LDHA', 'ANGPT2', 'IGFBP3', 'VEGFA']",0.999985189739908,0,0,4
146,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.42879907696245284,2.110450160771704,1.7870591752758826,['GSTP1'],0.999985189739908,0,0,1
147,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.42879907696245284,2.110450160771704,1.7870591752758826,['CYP2C18'],0.999985189739908,0,0,1
148,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.42879907696245284,2.110450160771704,1.7870591752758826,['ABCB1'],0.999985189739908,0,0,1
149,Mitochondrial fatty acid synthesis pathway WP4317,0.42879907696245284,2.110450160771704,1.7870591752758826,['HSD17B12'],0.999985189739908,0,0,1
150,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.42879907696245284,2.110450160771704,1.7870591752758826,['DLL3'],0.999985189739908,0,0,1
151,Tgif disruption of Shh signaling WP3674,0.42879907696245284,2.110450160771704,1.7870591752758826,['GLI3'],0.999985189739908,0,0,1
152,Glioblastoma signaling pathways WP2261,0.43059384751223906,1.1175995284991824,0.9416781669679477,"['CDKN1B', 'PRKCH', 'CDKN2C', 'CCND1', 'PRKCD', 'GAB1', 'SPRY2', 'BRCA1', 'FOXO4']",0.999985189739908,0,0,9
153,Apoptosis Modulation and Signaling WP1772,0.4333118967891119,1.1258397932816537,0.9415369981862449,"['NFKBIA', 'CASP7', 'CASP8', 'ENDOG', 'IL1R1', 'BAG3', 'CYCS', 'PTPN13']",0.999985189739908,0,0,8
154,Fatty acid beta-oxidation WP143,0.44427788661839157,1.2060935198821796,0.9785097532771083,"['TPI1', 'CPT2', 'ACSL5', 'CPT1B']",0.999985189739908,0,0,4
155,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.4456677426381365,1.407014157014157,1.1371229192284162,"['RPH3AL', 'SYTL4']",0.999985189739908,0,0,2
156,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.4456677426381365,1.407014157014157,1.1371229192284162,"['EGF', 'HSPB1']",0.999985189739908,0,0,2
157,Fatty acid transporters WP5061,0.4456677426381365,1.407014157014157,1.1371229192284162,"['ACSL5', 'ACSBG2']",0.999985189739908,0,0,2
158,Mammalian disorder of sexual development WP4842,0.4456677426381365,1.407014157014157,1.1371229192284162,"['MAPK11', 'FST']",0.999985189739908,0,0,2
159,Riboflavin and CoQ disorders WP5037,0.4456677426381365,1.407014157014157,1.1371229192284162,"['RFK', 'SLC52A1']",0.999985189739908,0,0,2
160,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.4456677426381365,1.407014157014157,1.1371229192284162,"['TGFB1', 'FN1']",0.999985189739908,0,0,2
161,Type II diabetes mellitus WP1584,0.4456677426381365,1.407014157014157,1.1371229192284162,"['KCNJ11', 'PRKCD']",0.999985189739908,0,0,2
162,Cannabinoid receptor signaling WP3869,0.44620707595315173,1.2663554410817772,1.0219135588403774,"['MAPK11', 'ADORA2A', 'PRKAR1A']",0.999985189739908,0,0,3
163,G1 to S cell cycle control WP45,0.45834362812367574,1.1256774193548387,0.8781815877873532,"['CDKN1C', 'CDKN1B', 'PCNA', 'CDKN2C', 'CCND1', 'RPA3']",0.999985189739908,0,0,6
164,Translation Factors WP107,0.45834362812367574,1.1256774193548387,0.8781815877873532,"['EIF4A2', 'EIF5A', 'EEF1G', 'EEF1A1', 'EIF1AX', 'EEF1A2']",0.999985189739908,0,0,6
165,Cell cycle WP179,0.46743203776004116,1.0674701484209352,0.811812451166642,"['CDKN1C', 'CCNA2', 'TGFB1', 'CDKN1B', 'PCNA', 'CDKN2C', 'CCND1', 'PTTG1', 'BUB3', 'YWHAG', 'SMC1B']",0.999985189739908,0,0,11
166,Parkinson's disease pathway WP2371,0.4685928865103501,1.164415215072876,0.8826511081084747,"['MAPK11', 'CASP7', 'CYCS', 'UBE2L6']",0.999985189739908,0,0,4
167,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.4685928865103501,1.164415215072876,0.8826511081084747,"['NFKBIA', 'CASP7', 'CASP8', 'TNFSF12']",0.999985189739908,0,0,4
168,Breast cancer pathway WP4262,0.47177418406758953,1.0553305249513933,0.7928221556604094,"['SHC4', 'SHC3', 'EGF', 'NOTCH4', 'BRCA1', 'FGF1', 'WNT16', 'DLL3', 'FGF17', 'SFRP4', 'FRAT2', 'CCND1', 'HEY1']",0.999985189739908,0,0,13
169,Photodynamic therapy-induced unfolded protein response WP3613,0.4748743883992072,1.2059608131726611,0.8980849935815262,"['PPP1R15A', 'XBP1', 'HSPA5']",0.999985189739908,0,0,3
170,Eicosanoid Synthesis WP167,0.4823341011113784,1.2986832986832988,0.9468936930276769,"['ALOX5', 'ALOX12']",0.999985189739908,0,0,2
171,Mitochondrial complex III assembly WP4921,0.4823341011113784,1.2986832986832988,0.9468936930276769,"['UQCC3', 'UQCR10']",0.999985189739908,0,0,2
172,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.4823341011113784,1.2986832986832988,0.9468936930276769,"['CCND1', 'VEGFA']",0.999985189739908,0,0,2
173,PPAR-alpha pathway WP2878,0.4823341011113784,1.2986832986832988,0.9468936930276769,"['CCND1', 'CPT2']",0.999985189739908,0,0,2
174,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.4843889865128666,1.1107434931623061,0.8051413080010988,"['PPP1R15A', 'XBP1', 'HSPA5', 'PPP1R1A', 'PPP1R1C']",0.999985189739908,0,0,5
175,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.48933490283146636,1.6882315112540194,1.2065928219690443,['SPI1'],0.999985189739908,0,0,1
176,Biogenic Amine Synthesis WP550,0.48933490283146636,1.6882315112540194,1.2065928219690443,['PAH'],0.999985189739908,0,0,1
177,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.48933490283146636,1.6882315112540194,1.2065928219690443,['HSD11B1'],0.999985189739908,0,0,1
178,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.48933490283146636,1.6882315112540194,1.2065928219690443,['SPI1'],0.999985189739908,0,0,1
179,Methylation Pathways WP704,0.48933490283146636,1.6882315112540194,1.2065928219690443,['NNMT'],0.999985189739908,0,0,1
180,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.48933490283146636,1.6882315112540194,1.2065928219690443,['STRADB'],0.999985189739908,0,0,1
181,Peroxiredoxin 2 induced ovarian failure WP4873,0.48933490283146636,1.6882315112540194,1.2065928219690443,['PRDX2'],0.999985189739908,0,0,1
182,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.48933490283146636,1.6882315112540194,1.2065928219690443,['NFKBIA'],0.999985189739908,0,0,1
183,Small Ligand GPCRs WP247,0.48933490283146636,1.6882315112540194,1.2065928219690443,['S1PR3'],0.999985189739908,0,0,1
184,Tamoxifen metabolism WP691,0.48933490283146636,1.6882315112540194,1.2065928219690443,['CYP3A5'],0.999985189739908,0,0,1
185,Urea cycle and related diseases WP4571,0.48933490283146636,1.6882315112540194,1.2065928219690443,['SLC25A15'],0.999985189739908,0,0,1
186,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.48936729545994706,1.0743822994307177,0.7677986679497408,"['SFRP4', 'FRAT2', 'CCND1', 'NOTUM', 'WNT16', 'DKK1', 'CXXC4']",0.999985189739908,0,0,7
187,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.4925066735114346,1.1255154639175258,0.7971432526193051,"['IFITM3', 'MAPK11', 'IFITM2', 'IFI27']",0.999985189739908,0,0,4
188,Signal transduction through IL1R WP4496,0.5028355613449997,1.1510566059825558,0.7913422981107806,"['NFKBIA', 'TGFB1', 'IL1R1']",0.999985189739908,0,0,3
189,Neural Crest Differentiation WP2064,0.5068098571401581,1.0551162040025823,0.7170774214059072,"['DLX5', 'NOTCH4', 'MYB', 'ASCL1', 'ETS1', 'RHOB', 'DLL3']",0.999985189739908,0,0,7
190,Glycosaminoglycan degradation WP4815,0.5174585317950742,1.2058282772568487,0.7944308865645634,"['HYAL1', 'HYAL2']",0.999985189739908,0,0,2
191,miRNA targets in ECM and membrane receptors WP2911,0.5174585317950742,1.2058282772568487,0.7944308865645634,"['LAMB2', 'FN1']",0.999985189739908,0,0,2
192,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.5174585317950742,1.2058282772568487,0.7944308865645634,"['NFKBIA', 'NFKBIE']",0.999985189739908,0,0,2
193,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.530008955604083,1.1009266776785465,0.6989358245991683,"['TGFB1', 'PROM1', 'MFGE8']",0.999985189739908,0,0,3
194,PI3K-Akt signaling pathway WP4172,0.5319383013834816,0.9998730811259252,0.6311476564911678,"['CDKN1B', 'HSP90AB1', 'PDGFB', 'BRCA1', 'FGF1', 'RELN', 'CCND1', 'GNG4', 'PDGFD', 'MYB', 'PCK2', 'HSP90AA1', 'ANGPT2', 'LAMB3', 'EGF', 'LAMB2', 'FN1', 'VEGFC', 'VEGFA', 'FGF17', 'LPAR6', 'IL7', 'DDIT4', 'IL3RA', 'FGFR4']",0.999985189739908,0,0,25
195,3q29 copy number variation syndrome WP4906,0.5340426891783491,1.033469387755102,0.6482741617832442,"['CASP7', 'TGFB1', 'DYNLT3', 'SLC51A', 'DYNLRB1', 'DYNLL2']",0.999985189739908,0,0,6
196,AGE/RAGE pathway WP2324,0.5340426891783491,1.033469387755102,0.6482741617832442,"['NFKBIA', 'CASP8', 'PRKCD', 'CYCS', 'FOXO4', 'TIRAP']",0.999985189739908,0,0,6
197,Oncostatin M Signaling Pathway WP2374,0.5340426891783491,1.033469387755102,0.6482741617832442,"['NFKBIA', 'CASP7', 'CDKN1B', 'PRKCH', 'PRKCD', 'VEGFA']",0.999985189739908,0,0,6
198,Folate Metabolism WP176,0.5388883884604295,1.0550096649484537,0.6522563503968094,"['SERPINA3', 'GPX2', 'GPX4', 'RFK']",0.999985189739908,0,0,4
199,Hedgehog Signaling Pathway WP4249,0.5388883884604295,1.0550096649484537,0.6522563503968094,"['EVC', 'CCND1', 'HHIP', 'GLI3']",0.999985189739908,0,0,4
200,Aspirin and miRNAs WP4707,0.5434588173355163,1.4067524115755627,0.8578395173924178,['VEGFA'],0.999985189739908,0,0,1
201,Estrogen metabolism WP697,0.5434588173355163,1.4067524115755627,0.8578395173924178,['ARSD'],0.999985189739908,0,0,1
202,Glucuronidation WP698,0.5434588173355163,1.4067524115755627,0.8578395173924178,['PGM5'],0.999985189739908,0,0,1
203,Liver X receptor pathway WP2874,0.5434588173355163,1.4067524115755627,0.8578395173924178,['ABCG5'],0.999985189739908,0,0,1
204,Mevalonate pathway WP3963,0.5434588173355163,1.4067524115755627,0.8578395173924178,['ACAT2'],0.999985189739908,0,0,1
205,Serotonin Transporter Activity WP1455,0.5434588173355163,1.4067524115755627,0.8578395173924178,['IL1R1'],0.999985189739908,0,0,1
206,Supression of HMGB1 mediated inflammation by THBD WP4479,0.5434588173355163,1.4067524115755627,0.8578395173924178,['NFKBIA'],0.999985189739908,0,0,1
207,Ebstein-Barr virus LMP1 signaling WP262,0.5509560625858705,1.1253539253539253,0.6708237159905092,"['NFKBIA', 'HSP90AA1']",0.999985189739908,0,0,2
208,Nicotine Activity on Dopaminergic Neurons WP1602,0.5509560625858705,1.1253539253539253,0.6708237159905092,"['CHRNB2', 'SLC18A2']",0.999985189739908,0,0,2
209,Intraflagellar transport proteins binding to dynein WP4532,0.5563285272127995,1.0549742433998712,0.6186329749357709,"['DYNLT3', 'DYNLRB1', 'DYNLL2']",0.999985189739908,0,0,3
210,Neovascularisation processes WP4331,0.5563285272127995,1.0549742433998712,0.6186329749357709,"['TGFB1', 'NOTCH4', 'PDGFB']",0.999985189739908,0,0,3
211,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5563285272127995,1.0549742433998712,0.6186329749357709,"['YAP1', 'FOXO4', 'FERMT3']",0.999985189739908,0,0,3
212,T-cell receptor (TCR) signaling pathway WP69,0.5578010366395381,1.0012364456018645,0.5844747241092672,"['NFKBIA', 'CD4', 'TGFB1', 'PRKCD', 'WAS', 'LCP2', 'CD247']",0.999985189739908,0,0,7
213,Endochondral Ossification with Skeletal Dysplasias WP4808,0.5658563815544586,1.0046513769918026,0.572063539531048,"['CDKN1C', 'ADAMTS5', 'TGFB1', 'GLI3', 'VEGFA']",0.999985189739908,0,0,5
214,Endochondral Ossification WP474,0.5658563815544586,1.0046513769918026,0.572063539531048,"['CDKN1C', 'ADAMTS5', 'TGFB1', 'GLI3', 'VEGFA']",0.999985189739908,0,0,5
215,Small cell lung cancer WP4658,0.5818635416024348,0.9735716771915867,0.5272078758581605,"['CDKN1C', 'NFKBIA', 'CDKN1B', 'CASP8', 'CCND1', 'LAMB3', 'LAMB2', 'FN1', 'CYCS']",0.999985189739908,0,0,9
216,miRNAs involvement in the immune response in sepsis WP4329,0.5827770022255677,1.0549388674388673,0.5696149443523072,"['NFKBIA', 'IRF1']",0.999985189739908,0,0,2
217,Vitamin D in inflammatory diseases WP4482,0.5827770022255677,1.0549388674388673,0.5696149443523072,"['NFKBIA', 'DUSP1']",0.999985189739908,0,0,2
218,Aryl Hydrocarbon Receptor Netpath WP2586,0.5830160806356055,0.9927986658580958,0.5356550989478556,"['HSP90AA1', 'CDKN1B', 'AIP', 'VEGFA']",0.999985189739908,0,0,4
219,Integrated Cancer Pathway WP1971,0.5830160806356055,0.9927986658580958,0.5356550989478556,"['CDKN1B', 'CASP8', 'BRCA1', 'BACH1']",0.999985189739908,0,0,4
220,PPAR signaling pathway WP3942,0.5851793022812528,0.981212421093668,0.5257698995601205,"['CPT2', 'ACSL5', 'CPT1B', 'ACSBG2', 'PCK2']",0.999985189739908,0,0,5
221,Synaptic Vesicle Pathway WP2267,0.5851793022812528,0.981212421093668,0.5257698995601205,"['RAB3A', 'SLC32A1', 'SYN3', 'SLC18A2', 'VAMP2']",0.999985189739908,0,0,5
222,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5877292028901402,0.9736228287841191,0.5174698007351703,"['YAP1', 'NFKBIA', 'MAPK11', 'CASP7', 'ANGPT2', 'FN1']",0.999985189739908,0,0,6
223,Biomarkers for urea cycle disorders WP4583,0.5918495741927711,1.2056959118052366,0.6323908503830036,['F10'],0.999985189739908,0,0,1
224,"Degradation pathway of sphingolipids, including diseases WP4153",0.5918495741927711,1.2056959118052366,0.6323908503830036,['NEU1'],0.999985189739908,0,0,1
225,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.5918495741927711,1.2056959118052366,0.6323908503830036,['TIFA'],0.999985189739908,0,0,1
226,Leptin and adiponectin WP3934,0.5918495741927711,1.2056959118052366,0.6323908503830036,['LEPR'],0.999985189739908,0,0,1
227,Mitochondrial CII Assembly WP4920,0.5918495741927711,1.2056959118052366,0.6323908503830036,['SDHAF1'],0.999985189739908,0,0,1
228,Nephrogenesis WP5052,0.5918495741927711,1.2056959118052366,0.6323908503830036,['ALDH1A2'],0.999985189739908,0,0,1
229,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.5918495741927711,1.2056959118052366,0.6323908503830036,['TGFB1'],0.999985189739908,0,0,1
230,Adipogenesis WP236,0.5988164139088142,0.958705750911443,0.49162451564449283,"['GDF10', 'SFRP4', 'CYP26A1', 'BMP2', 'TGFB1', 'ASIP', 'NDN', 'ID3', 'MIF', 'PCK2']",0.999985189739908,0,0,10
231,Metabolic reprogramming in colon cancer WP4290,0.604139530435945,0.964359351988218,0.4859889890454388,"['LDHA', 'PGAM1', 'SLC16A3', 'GAPDH']",0.999985189739908,0,0,4
232,Prion disease pathway WP3995,0.6062118056442217,0.9736737827529843,0.48734888772024837,"['PRNP', 'SPI1', 'HSPA5']",0.999985189739908,0,0,3
233,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6063111011769917,0.9525708573689581,0.4766303130239994,"['SFRP4', 'FRAT2', 'CCND1', 'NOTUM', 'WNT16', 'DKK1', 'CXXC4']",0.999985189739908,0,0,7
234,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6129004263732223,0.9928079339844046,0.48603189682133857,"['LDHA', 'VEGFA']",0.999985189739908,0,0,2
235,NAD+ biosynthetic pathways WP3645,0.6129004263732223,0.9928079339844046,0.48603189682133857,"['NMNAT1', 'ACMSD']",0.999985189739908,0,0,2
236,Ovarian infertility WP34,0.6129004263732223,0.9928079339844046,0.48603189682133857,"['CDKN1B', 'MSH5']",0.999985189739908,0,0,2
237,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.6129004263732223,0.9928079339844046,0.48603189682133857,"['HTR7', 'RPS6KA5']",0.999985189739908,0,0,2
238,Triacylglyceride synthesis WP325,0.6129004263732223,0.9928079339844046,0.48603189682133857,"['MOGAT1', 'AGPAT1']",0.999985189739908,0,0,2
239,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6225720658318936,0.9373385012919897,0.4442008623067711,"['SHC4', 'SHC3', 'CCND1', 'EGF', 'PDGFD', 'GAB1', 'PDGFB', 'VEGFA']",0.999985189739908,0,0,8
240,TGF-beta Receptor Signaling WP560,0.6245986651914003,0.9375,0.44123059799711367,"['TGFB1', 'EGF', 'FST', 'LTBP1']",0.999985189739908,0,0,4
241,MAPK Signaling Pathway WP382,0.6265118341460694,0.9469734710585448,0.44279306729771856,"['DUSP4', 'HSPA8', 'TGFB1', 'HSPA1L', 'IL1R1', 'DUSP1', 'EGF', 'RASGRF2', 'PRKCD', 'PDGFB', 'HSPB1', 'FGF1', 'DUSP7', 'RASGRP3', 'FGF17', 'MAPK11', 'RPS6KA5', 'DUSP10', 'MAPKAPK3', 'FGFR4', 'HSPA1B']",0.999985189739908,0,0,21
242,Base Excision Repair WP4752,0.6297091545812207,0.9375402446877013,0.4336097620460509,"['PCNA', 'TDG', 'APEX2']",0.999985189739908,0,0,3
243,Purine metabolism WP4792,0.6351141168369926,1.054903536977492,0.4788740773933179,['PRPS1'],0.999985189739908,0,0,1
244,Monoamine Transport WP727,0.6413286467799172,0.9375804375804376,0.41648564765762114,"['ADORA2A', 'IL1R1']",0.999985189739908,0,0,2
245,Striated Muscle Contraction Pathway WP383,0.6413286467799172,0.9375804375804376,0.41648564765762114,"['TNNT2', 'ACTG1']",0.999985189739908,0,0,2
246,Retinoblastoma gene in cancer WP2446,0.6518604701610891,0.9083974772806277,0.38872575680528837,"['CCNA2', 'ANLN', 'CDKN1B', 'PCNA', 'CCND1', 'H2AFZ', 'RPA3']",0.999985189739908,0,0,7
247,BDNF-TrkB Signaling WP3676,0.6522173591425569,0.9039876736270812,0.3863439013100404,"['TRPC3', 'HOMER1', 'GAB1']",0.999985189739908,0,0,3
248,miRNA regulation of prostate cancer signaling pathways WP3981,0.6522173591425569,0.9039876736270812,0.3863439013100404,"['NFKBIA', 'CDKN1B', 'CCND1']",0.999985189739908,0,0,3
249,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.6634476386020253,0.8880222463374933,0.3643602743966897,"['CCNA2', 'MAPK11', 'HSP90AA1', 'CCND1']",0.999985189739908,0,0,4
250,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6680825280510113,0.8881663618505724,0.3582361894463246,"['ANGPT2', 'LTBP1']",0.999985189739908,0,0,2
251,TLR4 Signaling and Tolerance WP3851,0.6680825280510113,0.8881663618505724,0.3582361894463246,"['NFKBIA', 'TIRAP']",0.999985189739908,0,0,2
252,Toll-like Receptor Signaling related to MyD88 WP3858,0.6680825280510113,0.8881663618505724,0.3582361894463246,"['TICAM2', 'TIRAP']",0.999985189739908,0,0,2
253,Apoptosis WP254,0.669434425761585,0.8878777589134126,0.3563249345549376,"['NFKBIA', 'CASP7', 'CASP8', 'IRF1', 'CYCS', 'NFKBIE']",0.999985189739908,0,0,6
254,Prostaglandin Synthesis and Regulation WP98,0.6737283194140837,0.872749072984435,0.34467333936089894,"['HSD11B1', 'HPGD', 'ANXA2']",0.999985189739908,0,0,3
255,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.6737951712970036,0.9376205787781351,0.37019990277123715,['VEGFA'],0.999985189739908,0,0,1
256,Dopamine metabolism WP2436,0.6737951712970036,0.9376205787781351,0.37019990277123715,['TYR'],0.999985189739908,0,0,1
257,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.6737951712970036,0.9376205787781351,0.37019990277123715,['MAFF'],0.999985189739908,0,0,1
258,Nanoparticle triggered regulated necrosis WP2513,0.6737951712970036,0.9376205787781351,0.37019990277123715,['CASP8'],0.999985189739908,0,0,1
259,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.6737951712970036,0.9376205787781351,0.37019990277123715,['TIFA'],0.999985189739908,0,0,1
260,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6904490976419945,0.8606692193318333,0.3188030907478963,"['CDKN1B', 'FN1', 'PFN4', 'WNT16', 'NEFH']",0.999985189739908,0,0,5
261,DNA damage response WP707,0.6904490976419945,0.8606692193318333,0.3188030907478963,"['CDKN1B', 'CASP8', 'CCND1', 'CYCS', 'BRCA1']",0.999985189739908,0,0,5
262,7-oxo-C and 7beta-HC pathways WP5064,0.6931975352761772,0.8436936936936937,0.3091633505847956,"['HSD11B1', 'ACOT6']",0.999985189739908,0,0,2
263,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6931975352761772,0.8436936936936937,0.3091633505847956,"['CCND1', 'ATP2C2']",0.999985189739908,0,0,2
264,Signal Transduction of S1P Receptor WP26,0.6931975352761772,0.8436936936936937,0.3091633505847956,"['SPHK1', 'S1PR3']",0.999985189739908,0,0,2
265,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6931975352761772,0.8436936936936937,0.3091633505847956,"['CCND1', 'DKK1']",0.999985189739908,0,0,2
266,Corticotropin-releasing hormone signaling pathway WP2355,0.6941213876483834,0.8681217483765618,0.31695856305493353,"['NFKBIA', 'CRHBP', 'HSP90AA1', 'TGFB1', 'PRKCD', 'IL18', 'CRH']",0.999985189739908,0,0,7
267,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6942418424610655,0.8435930457179652,0.3078565463193068,"['NFKBIA', 'HCK', 'TEC']",0.999985189739908,0,0,3
268,Type 2 papillary renal cell carcinoma WP4241,0.6942418424610655,0.8435930457179652,0.3078565463193068,"['TGFB1', 'PDGFB', 'VEGFA']",0.999985189739908,0,0,3
269,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.6994626240043446,0.8434922680412371,0.3015003382314687,"['NFKBIA', 'CD4', 'IL5', 'LCP2']",0.999985189739908,0,0,4
270,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6994626240043446,0.8434922680412371,0.3015003382314687,"['TGFB1', 'EGF', 'FST', 'LTBP1']",0.999985189739908,0,0,4
271,15q13.3 copy number variation syndrome WP4942,0.7083780369544873,0.8437942122186495,0.2909211554600246,['CHRFAM7A'],0.999985189739908,0,0,1
272,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.7083780369544873,0.8437942122186495,0.2909211554600246,['BMP2'],0.999985189739908,0,0,1
273,Leptin Insulin Overlap WP3935,0.7083780369544873,0.8437942122186495,0.2909211554600246,['LEPR'],0.999985189739908,0,0,1
274,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.7083780369544873,0.8437942122186495,0.2909211554600246,['NFKBIA'],0.999985189739908,0,0,1
275,"NAD metabolism, sirtuins and aging WP3630",0.7083780369544873,0.8437942122186495,0.2909211554600246,['ROS1'],0.999985189739908,0,0,1
276,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.7083780369544873,0.8437942122186495,0.2909211554600246,['SOX4'],0.999985189739908,0,0,1
277,Neuroinflammation WP4919,0.7083780369544873,0.8437942122186495,0.2909211554600246,['NFKBIA'],0.999985189739908,0,0,1
278,RalA downstream regulated genes WP2290,0.7083780369544873,0.8437942122186495,0.2909211554600246,['YBX3'],0.999985189739908,0,0,1
279,Serotonin and anxiety-related events WP3944,0.7083780369544873,0.8437942122186495,0.2909211554600246,['CRH'],0.999985189739908,0,0,1
280,DNA Replication WP466,0.7137645800044747,0.816318052468687,0.2752641541267898,"['PCNA', 'RPA3', 'GMNN']",0.999985189739908,0,0,3
281,Regulation of toll-like receptor signaling pathway WP1449,0.7155206870960934,0.8538252706636574,0.28581354181707086,"['NFKBIA', 'MAPK11', 'TICAM2', 'CASP8', 'PELI3', 'SFTPD', 'TIFA', 'TIRAP']",0.999985189739908,0,0,8
282,RANKL/RANK signaling pathway WP2018,0.7163965067280079,0.8228564244405331,0.2744402965840543,"['NFKBIA', 'SPI1', 'CALCR', 'PAPSS2']",0.999985189739908,0,0,4
283,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.7163965067280079,0.8228564244405331,0.2744402965840543,"['NFKBIA', 'MAPK11', 'RPS6KA5', 'IL1R1']",0.999985189739908,0,0,4
284,DNA Mismatch Repair WP531,0.7167204097511277,0.803456517742232,0.26760682768620436,"['PCNA', 'RPA3']",0.999985189739908,0,0,2
285,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.7167204097511277,0.803456517742232,0.26760682768620436,"['TICAM2', 'TIRAP']",0.999985189739908,0,0,2
286,Fluoropyrimidine Activity WP1601,0.7167204097511277,0.803456517742232,0.26760682768620436,"['TDG', 'TYMP']",0.999985189739908,0,0,2
287,miRNA regulation of DNA damage response WP1530,0.7211691165252567,0.8267910645883112,0.27026279508211415,"['CDKN1B', 'CASP8', 'CCND1', 'CYCS', 'BRCA1']",0.999985189739908,0,0,5
288,Head and Neck Squamous Cell Carcinoma WP4674,0.7268492930722162,0.829402432575357,0.2646093362478661,"['CASP8', 'CCND1', 'DDIT4', 'GAB1', 'FAT1', 'VEGFA']",0.999985189739908,0,0,6
289,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.732309046948594,0.7907477462974888,0.24635956282693508,"['MSTN', 'IGFBP5', 'TNFSF9']",0.999985189739908,0,0,3
290,Modulators of TCR signaling and T cell activation WP5072,0.7326168101206466,0.8032032400589102,0.2499026184838128,"['NFKBIA', 'CDKN1B', 'LCP2', 'CD247']",0.999985189739908,0,0,4
291,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7387063847308304,0.7668772668772669,0.23225242392712783,"['MAPK11', 'BMP2']",0.999985189739908,0,0,2
292,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7387063847308304,0.7668772668772669,0.23225242392712783,"['CCND1', 'FGF1']",0.999985189739908,0,0,2
293,Biomarkers for pyrimidine metabolism disorders WP4584,0.7392966593296219,0.7670271850336159,0.2316851673321185,['TYMP'],0.999985189739908,0,0,1
294,Hedgehog Signaling Pathway Netpath WP47,0.7392966593296219,0.7670271850336159,0.2316851673321185,['GLI3'],0.999985189739908,0,0,1
295,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.7392966593296219,0.7670271850336159,0.2316851673321185,['TGFB1'],0.999985189739908,0,0,1
296,Overview of nanoparticle effects WP3287,0.7392966593296219,0.7670271850336159,0.2316851673321185,['FN1'],0.999985189739908,0,0,1
297,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.7392966593296219,0.7670271850336159,0.2316851673321185,['SFRP4'],0.999985189739908,0,0,1
298,Gastrin signaling pathway WP4659,0.7452271125593664,0.8336589073499222,0.24515095532162254,"['NFKBIA', 'BMP2', 'PRKCH', 'CDKN1B', 'CCND1', 'ANXA2', 'PRKCD', 'RHOB', 'VEGFA']",0.999985189739908,0,0,9
299,Glycogen Synthesis and Degradation WP500,0.74989272156646,0.7667271556518176,0.220683336038229,"['PHKG1', 'CALM3', 'GYG2']",0.999985189739908,0,0,3
300,NO/cGMP/PKG mediated Neuroprotection WP4008,0.74989272156646,0.7667271556518176,0.220683336038229,"['NFKBIA', 'CNGB3', 'CYCS']",0.999985189739908,0,0,3
301,Notch Signaling WP268,0.74989272156646,0.7667271556518176,0.220683336038229,"['KCNJ5', 'NOTCH4', 'DLL3']",0.999985189739908,0,0,3
302,Glycosylation and related congenital defects WP4521,0.7592168636325076,0.7334788204353422,0.20204981135988276,"['PMM2', 'DOLK']",0.999985189739908,0,0,2
303,Sphingolipid pathway WP1422,0.7592168636325076,0.7334788204353422,0.20204981135988276,"['SPHK1', 'SERINC1']",0.999985189739908,0,0,2
304,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.7629430159079686,0.7665768509840675,0.2074141817044421,"['BMP2', 'TGFB1', 'MSTN', 'ACTB']",0.999985189739908,0,0,4
305,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.7665372266340894,0.74411954092648,0.1978405616073344,"['CASP8', 'TGFB1', 'CXCL17']",0.999985189739908,0,0,3
306,Phytochemical activity on NRF2 transcriptional activation WP3,0.7669390610906522,0.7030546623794213,0.18655410057751926,['AIMP2'],0.999985189739908,0,0,1
307,Pyrimidine metabolism and related diseases WP4225,0.7669390610906522,0.7030546623794213,0.18655410057751926,['TYMP'],0.999985189739908,0,0,1
308,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7764393430544285,0.8583694380316877,0.21719901743037023,"['HSP90AA1', 'CDKN1B', 'HSP90AB1', 'ANGPT2', 'LAMB3', 'EGF', 'LAMB2', 'PDGFB', 'FN1', 'VEGFC', 'FGF1', 'VEGFA', 'FGF17', 'RELN', 'LPAR6', 'GNG4', 'PDGFD', 'DDIT4', 'IL3RA', 'FGFR4', 'PELO']",0.999985189739908,0,0,21
309,VEGFA-VEGFR2 Signaling Pathway WP3888,0.7767506850939865,0.8856648199445983,0.2237506834581796,"['NOTCH4', 'HSPB1', 'FOXO4', 'ETS1', 'APOLD1', 'ACTG1', 'TUBB8', 'PRDX2', 'LDHA', 'RPS6KA5', 'CCND1', 'DNAJB4', 'SH3BGRL3', 'MYH11', 'IER5', 'SLC25A25', 'DUSP5', 'HSP90AA1', 'TRPC3', 'IGFBP3', 'PRKCD', 'FN1', 'GAB1', 'BMX', 'DKK1', 'VEGFA', 'NFKBIA', 'BMP2', 'NR4A3', 'TXNIP', 'CYCS', 'ALDOA', 'GAPDH', 'SLC25A11', 'FJX1', 'ARF6']",0.999985189739908,0,0,36
310,Endothelin Pathways WP2197,0.7783174946686346,0.7028635778635779,0.1761521950753916,"['ADCY10', 'NPY1R']",0.999985189739908,0,0,2
311,Ethanol effects on histone modifications WP3996,0.7783174946686346,0.7028635778635779,0.1761521950753916,"['ALDH1A2', 'HAT1']",0.999985189739908,0,0,2
312,Nanoparticle-mediated activation of receptor signaling WP2643,0.7783174946686346,0.7028635778635779,0.1761521950753916,"['MAPK11', 'FN1']",0.999985189739908,0,0,2
313,Alzheimer's disease WP2059,0.7882460014502725,0.7662756598240469,0.1823315026903304,"['CASP7', 'CASP8', 'CYCS', 'CALM3', 'GAPDH', 'CDK5R1']",0.999985189739908,0,0,6
314,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7905208534840367,0.7331353653070372,0.1723331762056561,"['MAPK11', 'PRKCH', 'PRKCD', 'ETS1']",0.999985189739908,0,0,4
315,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7905208534840367,0.7331353653070372,0.1723331762056561,"['NFKBIA', 'MAPK11', 'CASP8', 'RNF125']",0.999985189739908,0,0,4
316,Differentiation of white and brown adipocyte WP2895,0.7916521993695517,0.6489240662874103,0.1516101580324265,['BMP2'],0.999985189739908,0,0,1
317,NAD+ metabolism WP3644,0.7916521993695517,0.6489240662874103,0.1516101580324265,['NMNAT1'],0.999985189739908,0,0,1
318,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7916521993695517,0.6489240662874103,0.1516101580324265,['LDHA'],0.999985189739908,0,0,1
319,Serotonin and anxiety WP3947,0.7916521993695517,0.6489240662874103,0.1516101580324265,['CRH'],0.999985189739908,0,0,1
320,Pre-implantation embryo WP3527,0.7960765838018744,0.6746975546975547,0.15387144805606875,"['DLX2', 'HNRNPAB']",0.999985189739908,0,0,2
321,Common Pathways Underlying Drug Addiction WP2636,0.797111570509719,0.7026722472633612,0.15933839577909345,"['PPP1R1A', 'ACTB', 'ACTG1']",0.999985189739908,0,0,3
322,Toll-like Receptor Signaling Pathway WP75,0.7999894187395924,0.7394210865655435,0.16500682724636045,"['NFKBIA', 'MAPK11', 'TICAM2', 'CASP8', 'TIRAP']",0.999985189739908,0,0,5
323,Notch Signaling Pathway Netpath WP61,0.8033139549283145,0.7174819039262996,0.1571354706708071,"['CCND1', 'HEY1', 'NOTCH4', 'DLL3']",0.999985189739908,0,0,4
324,IL-3 signaling pathway WP286,0.8110990805539487,0.6836288961208472,0.14312800586969715,"['HCK', 'TGFB1', 'IL3RA']",0.999985189739908,0,0,3
325,Regulation of Microtubule Cytoskeleton WP2038,0.8110990805539487,0.6836288961208472,0.14312800586969715,"['SPRED1', 'PARD6A', 'TESK2']",0.999985189739908,0,0,3
326,GABA receptor Signaling WP4159,0.8125637955465611,0.6486981486981487,0.1346443393090037,"['SLC32A1', 'GABRA6']",0.999985189739908,0,0,2
327,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.8125637955465611,0.6486981486981487,0.1346443393090037,"['CDKN1B', 'FOXO4']",0.999985189739908,0,0,2
328,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8125637955465611,0.6486981486981487,0.1346443393090037,"['CASP8', 'TGFB1']",0.999985189739908,0,0,2
329,Canonical and non-canonical TGF-B signaling WP3874,0.8137463087676012,0.6025264124942582,0.12418468327161994,['TGFB1'],0.999985189739908,0,0,1
330,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.8137463087676012,0.6025264124942582,0.12418468327161994,['MAPK11'],0.999985189739908,0,0,1
331,Autophagy WP4923,0.8278490993199515,0.6246246246246246,0.1180068251893116,"['MAP1LC3B', 'ATG101']",0.999985189739908,0,0,2
332,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8278490993199515,0.6246246246246246,0.1180068251893116,"['HEXIM1', 'NFKBIA']",0.999985189739908,0,0,2
333,Nuclear receptors WP170,0.8278490993199515,0.6246246246246246,0.1180068251893116,"['ESRRB', 'NR2F2']",0.999985189739908,0,0,2
334,Tumor suppressor activity of SMARCB1 WP4204,0.8278490993199515,0.6246246246246246,0.1180068251893116,"['H3F3B', 'GLI3']",0.999985189739908,0,0,2
335,Circadian rhythm related genes WP3594,0.8296687099481515,0.7874783776348979,0.14704489445962082,"['CHRNB2', 'MAGEL2', 'HOMER1', 'SFTPC', 'NR1D1', 'HCRTR2', 'PER2', 'HTR7', 'ADORA2A', 'NOCT', 'CRH', 'ID3', 'ATF5']",0.999985189739908,0,0,13
336,Globo Sphingolipid Metabolism WP1424,0.833498786664958,0.562315112540193,0.10241053351822967,['FUT2'],0.999985189739908,0,0,1
337,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.833498786664958,0.562315112540193,0.10241053351822967,['CPT2'],0.999985189739908,0,0,1
338,Transcription factor regulation in adipogenesis WP3599,0.833498786664958,0.562315112540193,0.10241053351822967,['PCK2'],0.999985189739908,0,0,1
339,Wnt signaling WP428,0.8368412810060217,0.7280682877842336,0.12968414584723395,"['SFRP4', 'FRAT2', 'CCND1', 'NOTUM', 'WNT16', 'DKK1', 'CXXC4']",0.999985189739908,0,0,7
340,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8420019235696187,0.6022706379849238,0.10357427651202264,"['PRKCH', 'PRKCD']",0.999985189739908,0,0,2
341,7q11.23 copy number variation syndrome WP4932,0.8451872571442444,0.7191342959265616,0.12095628157471786,"['CDKN1C', 'CLDN5', 'PCNA', 'UBE2L6', 'GAPDH', 'ATP5F1D', 'VAMP2']",0.999985189739908,0,0,7
342,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8482433514735824,0.6322118480360592,0.1040543023775491,"['ADCY10', 'TGFB1', 'BANF1']",0.999985189739908,0,0,3
343,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.8511576662722039,0.5271302250803859,0.0849511978887677,['EIF1AX'],0.999985189739908,0,0,1
344,Proteoglycan biosynthesis WP4784,0.8511576662722039,0.5271302250803859,0.0849511978887677,['PAPSS2'],0.999985189739908,0,0,1
345,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8511576662722039,0.5271302250803859,0.0849511978887677,['BCL2L14'],0.999985189739908,0,0,1
346,MECP2 and Associated Rett Syndrome WP3584,0.8512744940266896,0.6795303758241301,0.10941842127786089,"['GABRR2', 'DLX5', 'SST', 'TET3', 'OPRK1']",0.999985189739908,0,0,5
347,B Cell Receptor Signaling Pathway WP23,0.8557216427496483,0.6924259832081308,0.10788698898706424,"['NFKBIA', 'TEC', 'PRKCD', 'GAB1', 'ETS1', 'RASGRP3']",0.999985189739908,0,0,6
348,IL-4 signaling pathway WP395,0.8591297228550456,0.6167449311325052,0.09364368387948523,"['NFKBIA', 'MAPK11', 'HRH1']",0.999985189739908,0,0,3
349,Nucleotide Excision Repair WP4753,0.8591297228550456,0.6167449311325052,0.09364368387948523,"['PCNA', 'CETN2', 'RPA3']",0.999985189739908,0,0,3
350,ESC Pluripotency Pathways WP3931,0.8608484868403838,0.7019044544867656,0.10517109175482284,"['FGF17', 'EGF', 'PDGFB', 'GAB1', 'FGF1', 'FGFR4', 'WNT16']",0.999985189739908,0,0,7
351,TNF-alpha signaling pathway WP231,0.8637434118373815,0.6830165649520489,0.10004794632108903,"['NFKBIA', 'CASP7', 'HSP90AA1', 'CASP8', 'RFK', 'NFKBIE']",0.999985189739908,0,0,6
352,Wnt signaling pathway and pluripotency WP399,0.8637434118373815,0.6830165649520489,0.10004794632108903,"['PRKCH', 'CCND1', 'PRKCD', 'ESRRB', 'ZBTB33', 'WNT16']",0.999985189739908,0,0,6
353,Regulation of Actin Cytoskeleton WP51,0.8650122919036822,0.7320996681478148,0.10616291631380059,"['FGF17', 'EGF', 'CHRM5', 'PDGFB', 'FN1', 'WAS', 'FGF1', 'FGFR4', 'ACTB', 'ACTG1']",0.999985189739908,0,0,10
354,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8652907381260128,0.7217286914765907,0.10442671873715403,"['CLDN5', 'MAPK11', 'CLDN20', 'TGFB1', 'NOTCH4', 'EIF5A2', 'FN1', 'WNT16', 'DLL3']",0.999985189739908,0,0,9
355,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8669447235354366,0.49608473614526194,0.07083100851522484,['HPGD'],0.999985189739908,0,0,1
356,Nucleotide metabolism WP404,0.8669447235354366,0.49608473614526194,0.07083100851522484,['PRPS1'],0.999985189739908,0,0,1
357,Purine metabolism and related disorders WP4224,0.8669447235354366,0.49608473614526194,0.07083100851522484,['PRPS1'],0.999985189739908,0,0,1
358,Mitochondrial CIV Assembly WP4922,0.8671812671712761,0.562033462033462,0.08009384310440464,"['SCO2', 'HIGD1A']",0.999985189739908,0,0,2
359,Copper homeostasis WP3286,0.8693249292182246,0.6020145340815013,0.08430509912861471,"['PRNP', 'CCND1', 'SCO2']",0.999985189739908,0,0,3
360,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8693249292182246,0.6020145340815013,0.08430509912861471,"['EIF4A2', 'RPS6KA5', 'PRKCD']",0.999985189739908,0,0,3
361,Ras signaling WP4223,0.8716432914645598,0.742628009753124,0.10201852891917705,"['SHC4', 'HTR7', 'SHC3', 'GNG4', 'RASGRF2', 'GAB1', 'CALM3', 'FOXO4', 'FGFR4', 'ETS1', 'RASGRP3', 'ARF6']",0.999985189739908,0,0,12
362,Hepatitis B infection WP4666,0.8779701341101226,0.7081296932863728,0.09215791147048484,"['MAPK11', 'TICAM2', 'TGFB1', 'CASP8', 'PCNA', 'ATP6AP1', 'SLC10A1', 'CYCS', 'TIRAP']",0.999985189739908,0,0,9
363,Disruption of postsynaptic signaling by CNV WP4875,0.8783386203494968,0.5438618341844148,0.07055143620573487,"['HOMER1', 'YWHAG']",0.999985189739908,0,0,2
364,p38 MAPK Signaling Pathway WP400,0.8783386203494968,0.5438618341844148,0.07055143620573487,"['RPS6KA5', 'HSPB1']",0.999985189739908,0,0,2
365,Pathways Regulating Hippo Signaling WP4540,0.878678706470034,0.6649405772495756,0.08600073439523427,"['PRKCH', 'PRKD3', 'PRKAR1A', 'PRKCD', 'CDH24', 'FGFR4']",0.999985189739908,0,0,6
366,Immune response to tuberculosis WP4197,0.8810582550535111,0.4684887459807074,0.059325447369810685,['IRF1'],0.999985189739908,0,0,1
367,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8810582550535111,0.4684887459807074,0.059325447369810685,['SPHK1'],0.999985189739908,0,0,1
368,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8810582550535111,0.4684887459807074,0.059325447369810685,['HTR2B'],0.999985189739908,0,0,1
369,Statin inhibition of cholesterol production WP430,0.8810582550535111,0.4684887459807074,0.059325447369810685,['ABCG5'],0.999985189739908,0,0,1
370,Thermogenesis WP4321,0.8818903648623473,0.6775450234856748,0.08515896289046795,"['ADCY10', 'MAPK11', 'CPT2', 'ACSL5', 'CPT1B', 'ACTB', 'ACTG1']",0.999985189739908,0,0,7
371,AMP-activated protein kinase (AMPK) signaling WP1403,0.8841909104194863,0.6127460168697282,0.07541817537602842,"['CCNA2', 'STRADB', 'LEPR', 'CPT1B']",0.999985189739908,0,0,4
372,Pathways affected in adenoid cystic carcinoma WP3651,0.8841909104194863,0.6127460168697282,0.07541817537602842,"['MYCBP', 'MYB', 'BRCA1', 'FGFR4']",0.999985189739908,0,0,4
373,ATM Signaling Pathway WP2516,0.8886244688490248,0.5268259330759331,0.062207897225208295,"['NFKBIA', 'BRCA1']",0.999985189739908,0,0,2
374,Target Of Rapamycin (TOR) Signaling WP1471,0.8886244688490248,0.5268259330759331,0.062207897225208295,"['RRAGA', 'DDIT4']",0.999985189739908,0,0,2
375,Vitamin D-sensitive calcium signaling in depression WP4698,0.8886244688490248,0.5268259330759331,0.062207897225208295,"['GPX4', 'PVALB']",0.999985189739908,0,0,2
376,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8936755626099024,0.4437975968861059,0.04988838627955793,['CASP8'],0.999985189739908,0,0,1
377,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8936755626099024,0.4437975968861059,0.04988838627955793,['SCO2'],0.999985189739908,0,0,1
378,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8936755626099024,0.4437975968861059,0.04988838627955793,['NFKBIA'],0.999985189739908,0,0,1
379,Urea cycle and associated pathways WP4595,0.8936755626099024,0.4437975968861059,0.04988838627955793,['SLC25A15'],0.999985189739908,0,0,1
380,Netrin-UNC5B signaling pathway WP4747,0.8980981018964131,0.5108225108225108,0.05490114575428186,"['YAP1', 'NTN1']",0.999985189739908,0,0,2
381,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9042855123033511,0.610265466879713,0.06139889177783126,"['MC4R', 'PAX8', 'MAPKAPK3', 'DIO1', 'TSHR']",0.999985189739908,0,0,5
382,Fatty Acid Biosynthesis WP357,0.9049551743065984,0.42157556270096463,0.04210269565641482,['ACSL5'],0.999985189739908,0,0,1
383,Gastric Cancer Network 1 WP2361,0.9049551743065984,0.42157556270096463,0.04210269565641482,['KIF15'],0.999985189739908,0,0,1
384,Glycerolipids and Glycerophospholipids WP4722,0.9049551743065984,0.42157556270096463,0.04210269565641482,['CDIPT'],0.999985189739908,0,0,1
385,NRF2-ARE regulation WP4357,0.9049551743065984,0.42157556270096463,0.04210269565641482,['AIMP2'],0.999985189739908,0,0,1
386,PKC-gamma calcium signaling pathway in ataxia WP4760,0.9049551743065984,0.42157556270096463,0.04210269565641482,['TRPC3'],0.999985189739908,0,0,1
387,Ebola Virus Pathway on Host WP4217,0.9057512871270459,0.6475641853304862,0.06410272071417358,"['VPS18', 'HLA-A', 'MFGE8', 'ACTB', 'ACTG1', 'HLA-E', 'RHOB']",0.999985189739908,0,0,7
388,G13 Signaling Pathway WP524,0.9068160366286222,0.49576046634870163,0.04849314497537335,"['WAS', 'IQGAP2']",0.999985189739908,0,0,2
389,Chemokine signaling pathway WP3929,0.9077811508777003,0.6601307189542484,0.06386893609215918,"['SHC4', 'NFKBIA', 'HCK', 'SHC3', 'GNG4', 'PRKCD', 'WAS', 'CXCL14']",0.999985189739908,0,0,8
390,ErbB signaling pathway WP673,0.9100900249802439,0.6236559139784946,0.0587557186800912,"['SHC4', 'CDKN1B', 'SHC3', 'CCND1', 'EGF', 'GAB1']",0.999985189739908,0,0,6
391,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9148319400447,0.4815591101305387,0.04286593731267692,"['ACTB', 'ACTG1']",0.999985189739908,0,0,2
392,1q21.1 copy number variation syndrome WP4905,0.9150388317960791,0.401469912723932,0.035646021945121543,['FMO5'],0.999985189739908,0,0,1
393,Estrogen signaling pathway WP712,0.9150388317960791,0.401469912723932,0.035646021945121543,['GPER1'],0.999985189739908,0,0,1
394,Physiological and pathological hypertrophy of the heart WP1528,0.9150388317960791,0.401469912723932,0.035646021945121543,['MAPK11'],0.999985189739908,0,0,1
395,Sphingolipid Metabolism (general overview) WP4725,0.9150388317960791,0.401469912723932,0.035646021945121543,['SPHK1'],0.999985189739908,0,0,1
396,DNA IR-double strand breaks and cellular response via ATM WP3959,0.917832064305124,0.5265212491951062,0.04514437501751027,"['YAP1', 'PCNA', 'BRCA1']",0.999985189739908,0,0,3
397,Oxidative phosphorylation WP623,0.917832064305124,0.5265212491951062,0.04514437501751027,"['ATP6AP1', 'ATP6AP2', 'ATP5F1D']",0.999985189739908,0,0,3
398,Interleukin-11 Signaling Pathway WP2332,0.9221965977761339,0.46814671814671815,0.03791840878848183,"['TGFB1', 'BGLAP']",0.999985189739908,0,0,2
399,PDGF Pathway WP2526,0.9221965977761339,0.46814671814671815,0.03791840878848183,"['NFKBIA', 'PDGFB']",0.999985189739908,0,0,2
400,16p11.2 distal deletion syndrome WP4950,0.9240532662515998,0.38319204910844784,0.030266639177859114,['PLN'],0.999985189739908,0,0,1
401,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9240532662515998,0.38319204910844784,0.030266639177859114,['H3F3B'],0.999985189739908,0,0,1
402,MTHFR deficiency WP4288,0.9240532662515998,0.38319204910844784,0.030266639177859114,['CYCS'],0.999985189739908,0,0,1
403,Sphingolipid Metabolism (integrated pathway) WP4726,0.9240532662515998,0.38319204910844784,0.030266639177859114,['SPHK1'],0.999985189739908,0,0,1
404,TGF-beta Signaling Pathway WP366,0.9261705480895629,0.6350251084783775,0.04870444714044072,"['YAP1', 'TGFB1', 'PARD6A', 'CCND1', 'CITED1', 'FN1', 'NEDD9', 'ETS1']",0.999985189739908,0,0,8
405,Vitamin B12 metabolism WP1533,0.9321117875743907,0.36650356493778835,0.025766127040802295,['SERPINA3'],0.999985189739908,0,0,1
406,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9344294360788694,0.5346097201767305,0.03625678469040454,"['TGFB1', 'CCND1', 'CYCS', 'NTN1']",0.999985189739908,0,0,4
407,One-carbon metabolism and related pathways WP3940,0.9351609913070943,0.44343968028178554,0.029726680178472364,"['GPX2', 'GPX4']",0.999985189739908,0,0,2
408,Splicing factor NOVA regulated synaptic proteins WP4148,0.9351609913070943,0.44343968028178554,0.029726680178472364,"['NTNG1', 'NCDN']",0.999985189739908,0,0,2
409,Male infertility WP4673,0.9382659579355832,0.5803781979977753,0.03698276256336548,"['ABCB1', 'MSH5', 'DND1', 'EPSTI1', 'TEX15', 'ETV5']",0.999985189739908,0,0,6
410,Prolactin Signaling Pathway WP2037,0.9390748893067664,0.5262161726804123,0.033077974206570104,"['NFKBIA', 'TEC', 'IRF1', 'YWHAG']",0.999985189739908,0,0,4
411,Gastric Cancer Network 2 WP2363,0.939315704465447,0.3512057877813505,0.02198676168500467,['SNURF'],0.999985189739908,0,0,1
412,Oxidative Stress WP408,0.939315704465447,0.3512057877813505,0.02198676168500467,['NOX5'],0.999985189739908,0,0,1
413,Wnt signaling in kidney disease WP4150,0.939315704465447,0.3512057877813505,0.02198676168500467,['WNT16'],0.999985189739908,0,0,1
414,Androgen receptor signaling pathway WP138,0.943994769251897,0.5465263298919005,0.03149885586985044,"['CCND1', 'BRCA1', 'FKBP4', 'ETV5', 'RHOB']",0.999985189739908,0,0,5
415,G Protein Signaling Pathways WP35,0.943994769251897,0.5465263298919005,0.03149885586985044,"['PRKCH', 'PRKD3', 'PRKAR1A', 'GNG4', 'PRKCD']",0.999985189739908,0,0,5
416,Glycerophospholipid Biosynthetic Pathway WP2533,0.9457555950795513,0.33713183279742764,0.018802212978971878,['CDIPT'],0.999985189739908,0,0,1
417,Lipid Metabolism Pathway WP3965,0.9457555950795513,0.33713183279742764,0.018802212978971878,['PRKAR1A'],0.999985189739908,0,0,1
418,Oxysterols derived from cholesterol WP4545,0.9457555950795513,0.33713183279742764,0.018802212978971878,['ACOT6'],0.999985189739908,0,0,1
419,Resistin as a regulator of inflammation WP4481,0.9457555950795513,0.33713183279742764,0.018802212978971878,['NFKBIA'],0.999985189739908,0,0,1
420,White fat cell differentiation WP4149,0.9457555950795513,0.33713183279742764,0.018802212978971878,['NR2F2'],0.999985189739908,0,0,1
421,ATM Signaling Network in Development and Disease  WP3878,0.9460588916176459,0.4212033462033462,0.023355918699165312,"['HSPB1', 'CDK5R1']",0.999985189739908,0,0,2
422,Pancreatic adenocarcinoma pathway WP4263,0.9477370431838673,0.5394782522442096,0.028958219260262028,"['TGFB1', 'CCND1', 'EGF', 'PRKCD', 'VEGFA']",0.999985189739908,0,0,5
423,Proteasome Degradation WP183,0.9493419822415128,0.46780424983902125,0.024319358113434792,"['H2AFZ', 'HLA-A', 'HLA-E']",0.999985189739908,0,0,3
424,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9508303542618153,0.4108987035816304,0.020717356096697767,"['ATG101', 'CP']",0.999985189739908,0,0,2
425,Joubert Syndrome WP4656,0.9512686839176163,0.5025388521310971,0.025106202105188862,"['TMEM17', 'CETN2', 'UNC119', 'PDE6B']",0.999985189739908,0,0,4
426,Non-small cell lung cancer WP4255,0.9512686839176163,0.5025388521310971,0.025106202105188862,"['CASP8', 'CCND1', 'EGF', 'CYCS']",0.999985189739908,0,0,4
427,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9533436405395118,0.45926359538722705,0.021943546680915152,"['ACTB', 'SGCG', 'ACTG1']",0.999985189739908,0,0,3
428,Ciliopathies WP4803,0.9545196432836981,0.6288620302489928,0.02927167637092068,"['PKHD1', 'TMEM17', 'EVC', 'ARL2BP', 'MAK', 'DCDC2', 'UNC119', 'CCDC65', 'AK7', 'DNAI1', 'GLI3']",0.999985189739908,0,0,11
429,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9566586526634887,0.31211146838156484,0.01382923342474114,['NFKBIA'],0.999985189739908,0,0,1
430,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.9566586526634887,0.31211146838156484,0.01382923342474114,['CALM3'],0.999985189739908,0,0,1
431,The influence of laminopathies on Wnt signaling WP4844,0.9566586526634887,0.31211146838156484,0.01382923342474114,['CCND1'],0.999985189739908,0,0,1
432,Zinc homeostasis WP3529,0.9566586526634887,0.31211146838156484,0.01382923342474114,['SLC39A8'],0.999985189739908,0,0,1
433,DNA IR-damage and cellular response via ATR WP4016,0.9581057513955586,0.48789780367548186,0.020880620571344478,"['SEM1', 'BRIP1', 'PCNA', 'BRCA1']",0.999985189739908,0,0,4
434,Insulin Signaling WP481,0.9587497053228234,0.6090050059058439,0.02565447817164807,"['EHD1', 'MAPK11', 'XBP1', 'RPS6KA5', 'PRKCH', 'SHC3', 'PRKCD', 'GAB1', 'VAMP2', 'ARF6']",0.999985189739908,0,0,10
435,Melatonin metabolism and effects WP3298,0.9612589578942711,0.30094166283876894,0.011890638213989287,['PER2'],0.999985189739908,0,0,1
436,22q11.2 copy number variation syndrome WP4657,0.9632583735508745,0.5067853619507041,0.018970801789202275,"['CLDN5', 'CYP26A1', 'RELN', 'SERPIND1', 'ALDH1A2']",0.999985189739908,0,0,5
437,Endometrial cancer WP4155,0.9636449015809577,0.43540866398738814,0.016124232853943835,"['CCND1', 'EGF', 'FGF1']",0.999985189739908,0,0,3
438,DNA damage response (only ATM dependent) WP710,0.9658017805615001,0.5007138251819103,0.017423169699196987,"['TGFB1', 'CDKN1B', 'CCND1', 'WNT16', 'PCK2']",0.999985189739908,0,0,5
439,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9665736169226009,0.42799611468235343,0.014550932584201303,"['CDKN1B', 'PAX8', 'TSHR']",0.999985189739908,0,0,3
440,DNA Repair Pathways Full Network WP4946,0.9687521334385242,0.539880716176758,0.01713932102783279,"['BRIP1', 'PCNA', 'CETN2', 'TDG', 'RPA3', 'APEX2', 'BRCA1']",0.999985189739908,0,0,7
441,Wnt Signaling Pathway WP363,0.9692254880091887,0.36609590957417043,0.011443423158539405,"['GCKR', 'CCND1']",0.999985189739908,0,0,2
442,Melanoma WP4685,0.9692785933105185,0.42083065035415324,0.013131263966233243,"['CCND1', 'CALM3', 'ETS1']",0.999985189739908,0,0,3
443,Nonalcoholic fatty liver disease WP4396,0.9697389623618304,0.5556623315608517,0.017074589200265132,"['XBP1', 'CASP7', 'TGFB1', 'CASP8', 'NDUFB11', 'LEPR', 'CYCS', 'UQCR10']",0.999985189739908,0,0,8
444,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.972333189136738,0.27175604190436675,0.0076245902639834875,['GABRA6'],0.999985189739908,0,0,1
445,Cardiac Hypertrophic Response WP2795,0.9745448614734269,0.3507882882882883,0.009044979798815866,"['TGFB1', 'EGF']",0.999985189739908,0,0,2
446,Amyotrophic lateral sclerosis (ALS) WP2447,0.9752704861191378,0.2632435691318328,0.0065917307963788314,['NEFH'],0.999985189739908,0,0,1
447,IL-1 signaling pathway WP195,0.9768596452361179,0.34360307829695586,0.008044537036865565,"['NFKBIA', 'IL1R1']",0.999985189739908,0,0,2
448,IL-5 signaling pathway WP127,0.9778960903798167,0.25524700380005844,0.005705245714836984,['SPRED1'],0.999985189739908,0,0,1
449,Signaling of Hepatocyte Growth Factor Receptor WP313,0.9778960903798167,0.25524700380005844,0.005705245714836984,['GAB1'],0.999985189739908,0,0,1
450,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.97930036356476,0.5291664123379927,0.011068508762490041,"['SHC4', 'NFKBIA', 'BMP2', 'RAB3A', 'RPS6KA5', 'SHC3', 'PRKCD', 'CDK5R1']",0.999985189739908,0,0,8
451,MET in type 1 papillary renal cell carcinoma WP4205,0.9856935197541952,0.31166881166881166,0.0044910866729588285,"['GAB1', 'ETS1']",0.999985189739908,0,0,2
452,Hippo-Merlin Signaling Dysregulation WP4541,0.9881893755908501,0.395573074590661,0.004699773597076976,"['CCND1', 'PRKAR1A', 'CDH24', 'FGFR4']",0.999985189739908,0,0,4
453,Histone Modifications WP2369,0.9899267848268646,0.2104662379421222,0.0021308219244889916,['H3F3B'],0.999985189739908,0,0,1
454,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9903058828198777,0.2900856521546177,0.0028258435716474774,"['MAPK11', 'IL3RA']",0.999985189739908,0,0,2
455,Integrated breast cancer pathway WP1984,0.9908094292816713,0.4627216949721182,0.00427233929023164,"['PLK3', 'CASP8', 'CCND1', 'BRCA1', 'BACH1', 'RASGRP3', 'VEGFA']",0.999985189739908,0,0,7
456,Pyrimidine metabolism WP4022,0.9909106170796238,0.3408485755555942,0.0031122690487650727,"['POLR1C', 'POLR2K', 'TYMP']",0.999985189739908,0,0,3
457,Eukaryotic Transcription Initiation WP405,0.9909967058663468,0.2053172300211748,0.0018569031352021362,['POLR2K'],0.999985189739908,0,0,1
458,Mesodermal commitment pathway WP2857,0.9911664573722868,0.4117836689801646,0.0036536698816198366,"['YAP1', 'CCND1', 'PRKAR1A', 'SLC2A12', 'DKK1']",0.999985189739908,0,0,5
459,EGF/EGFR signaling pathway WP437,0.9928837915266959,0.4693807484505159,0.003352152765049106,"['RPS6KA5', 'PCNA', 'EGF', 'PRKCD', 'GAB1', 'SPRY2', 'FOXO4', 'ARF6']",0.999985189739908,0,0,8
460,Endoderm differentiation WP2853,0.9930214659515553,0.39992631481993185,0.002800683142099585,"['DUSP4', 'DUSP5', 'TGFB1', 'SLC2A12', 'DKK1']",0.999985189739908,0,0,5
461,Genotoxicity pathway WP4286,0.9948649513931215,0.18293023906053404,0.0009417757762204402,['PLK3'],0.999985189739908,0,0,1
462,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9948649513931215,0.18293023906053404,0.0009417757762204402,['HOMER1'],0.999985189739908,0,0,1
463,Ectoderm Differentiation WP2858,0.994923322788843,0.38513181788606343,0.0019601697182411626,"['MAFB', 'SPRY2', 'NR2F2', 'PTPN13', 'GLI3']",0.999985189739908,0,0,5
464,Interferon type I signaling pathways WP585,0.995897996922923,0.1752813504823151,0.0007204833638614152,['RPS6KA5'],0.999985189739908,0,0,1
465,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9963193834337838,0.30004139453592127,0.0011063746490133342,"['UQCR10', 'SLC25A5', 'ATP5F1D']",0.999985189739908,0,0,3
466,Kit receptor signaling pathway WP304,0.9963337516894053,0.1716910558435593,0.0006306187535638311,['TEC'],0.999985189739908,0,0,1
467,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9963337516894053,0.1716910558435593,0.0006306187535638311,['NDUFB11'],0.999985189739908,0,0,1
468,p53 transcriptional gene network WP4963,0.9963337516894053,0.1716910558435593,0.0006306187535638311,['RPRM'],0.999985189739908,0,0,1
469,Leptin signaling pathway WP2034,0.996388704197233,0.24723673253085018,0.0008944610300090794,"['CCND1', 'LEPR']",0.999985189739908,0,0,2
470,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9970421453259836,0.24013605442176872,0.0007113400906662618,"['TGFB1', 'EGF']",0.999985189739908,0,0,2
471,Fragile X Syndrome  WP4549,0.9988244485795398,0.29959039027982326,0.0003523910763701303,"['EEF1A1', 'HOMER1', 'PRKAR1A', 'GAB1']",0.999985189739908,0,0,4
472,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9989239887042366,0.2969163397500228,0.0003196573437823087,"['MAPK11', 'ABCG5', 'RPS6KA5', 'SHC3']",0.999985189739908,0,0,4
473,Integrin-mediated Cell Adhesion WP185,0.9990228343417068,0.20735020735020734,0.00020271456085434666,"['SHC3', 'MYPN']",0.999985189739908,0,0,2
474,Amino Acid metabolism WP3925,0.999564725525629,0.1235388689237753,5.378502270830302e-05,['LDHA'],0.999985189739908,0,0,1
475,Genes related to primary cilium development (based on CRISPR) WP4536,0.9998432364386586,0.1694161694161694,2.6560363969520873e-05,"['TMEM17', 'EVC']",0.999985189739908,0,0,2
476,Cytoplasmic Ribosomal Proteins WP477,0.9999399164599447,0.09754729679204367,5.861162995561867e-06,['RPS5'],0.999985189739908,0,0,1
477,Ciliary landscape WP4352,0.9999851851500671,0.2554641211323239,3.7846906527048605e-06,"['YAP1', 'DYNLT3', 'COPS7A', 'DYNLRB1', 'IQGAP2', 'DYNLL2']",0.999985189739908,0,0,6
478,mRNA Processing WP411,0.999985189739908,0.13500020758085274,1.9994029926194027e-06,"['CSTF2T', 'HNRNPAB']",0.999985189739908,0,0,2
